1. Gastroenterology board recertification

   • Rowen K. Zetterman

   Invited Commentary Pages: 435 - 436

2. Web alert

   News Pages: 437 - 438

3. Literature alert

   Abstract Pages: 439 - 442

4. Clinical trials report

   • M. Brian Fennerty

   BriefCommunication Pages: 445 - 447

5. Helicobacter pylori-associated diseases

   • Michael K. Sanders
   • David A. Peura

   OriginalPaper Pages: 448 - 454

6. Nonulcer dyspepsia

   • Nimish Vakil

   OriginalPaper Pages: 455 - 458

7. The pharmacology and clinical relevance of proton pump inhibitors

   • Philip O. Katz
   • Christine Frissora

   OriginalPaper Pages: 459 - 462

8. Gastric neoplasia

   • Pelayo Correa

   OriginalPaper Pages: 463 - 470

9. Treatment and management of Helicobacter pylori infection

   • Mae F. Go

   OriginalPaper Pages: 471 - 477

10. The pathogenesis of inflammatory bowel disease: Translational implications for clinicians

    • Maria T. Abreu

    OriginalPaper Pages: 481 - 489

11. Assessing disease activity and disease activity indices for inflammatory bowel disease

    • Feng Xiao Li
    • Lloyd R. Sutherland

    OriginalPaper Pages: 490 - 496

12. Evolving medical therapies for ulcerative colitis

    • Russell D. Cohen

    OriginalPaper Pages: 497 - 505

13. Advances in medical therapy for Crohn’s disease

    • Geert D’Haens
    • Marco Daperno

    OriginalPaper Pages: 506 - 512

14. Treatment of the extraintestinal manifestations of inflammatory bowel disease

    • Charles N. Bernstein

    OriginalPaper Pages: 513 - 516